(Philadelphia, PA) – The Abramson
Cancer Center of the University of Pennsylvania and the
national, non-profit Brain Tumor Society (BTS) are collaborating
to offer a one-day seminar for pediatric and adult brain tumor patients,
survivors, and caregivers. “Brain Tumors: Confronting the
Challenge Together” will be held Saturday, June 17th, in the
ground floor auditorium of the Biomedical Research Building (BRB)
II/III, Curie Boulevard and Osler Way, on the University of Pennsylvania’s
School of Medicine campus in Philadelphia.
The full-day seminar runs from 8:00 am to 4:00 pm, and will provide
updates on the latest advances in standard and experimental therapies,
guidance on integrating complementary and alternative medicine into
treatment, coping strategies for families dealing with treatment
and survivorship issues of children and adolescents, and an overview
of emerging strategies on the horizon in brain tumor treatment.
In addition to the presentations and break-out sessions, there will
also be an open forum where attendees will have the opportunity
to ask the experts questions. “Thanks to the Internet and
the media there is so much good information out there,” says
Myrna R. Rosenfeld, MD, PhD, Chief of Neuro-Oncology
at the University of Pennsylvania School of Medicine.
“However, along with the good, also comes bad, unreliable
information. There is just so much to sort through, it can be overwhelming.
This type of event brings the patient, caregiver, and survivor populations
together with the medical community in a forum where their questions
and concerns can be addressed directly and correctly.”
“A seminar like this is so important for our patients and
their loved ones,” said Sarah Gupta, LICSW, Director of Support
Services at the Brain Tumor Society. “It’s absolutely
essential for people affected by brain tumors to have opportunities
to connect with others in similar situations. Patients, survivors,
and caregivers may feel isolated in their experience until they
meet other people facing the same challenges.”
Penn neuro-oncologists Myrna Rosenfeld, MD, PhD, and Amy Pruitt,
MD, and neurosurgeons Kevin Judy, MD, and Donald O’Rourke,
MD, are among the presenters from the Abramson Cancer Center’s
Brain Tumor Program. Drs. Rosenfeld and O’Rourke are also
a past recipients of the BTS research grant awards.
Other presenters represent a number of regional cancer centers,
including Children’s Hospital of Philadelphia, Memorial Sloan-Kettering
Cancer Center, Thomas Jefferson University Hospital, and Columbia
University. Renowned physician Peter Phillips, MD, from Children’s
Hospital, and member of the BTS Scientific Advisory Council, will
also be presenting.
Each year, more than 200,000 adults and children in the United States
are diagnosed with a primary or metastatic brain tumor. There are
over 120 different types of brain tumors which are the leading cause
of solid tumor cancer death in children up to age 19 and the second
leading cause of cancer death in young adults ages 20 to 39. The
brain – the organ of the body that controls the functions
of all other organs – is responsible for the experience of
the five senses and is the seat of thought, emotions, language,
personality, creativity, and of course, memory. Because of their
location in this extraordinarily complex and vital organ, brain
tumors present unique challenges for patients, physicians, and caregivers
For more information about “Brain Tumors: Confronting the
Challenge Together” or to register, please visit www.tbts.org
and click on “One-day Seminar Series” or call 1-800-770-8287.
An all-inclusive fee of $25 per person includes breakfast, lunch,
The Abramson Cancer Center of the University of Pennsylvania
was established in 1973 as a center of excellence in cancer
research, patient care, education and outreach. It is one of a select
group of only 39 NCI-designated Comprehensive Cancer Centers in
the United States and is one of the top five in National Cancer
Institute (NCI) funding. Home to one of the largest clinical and
research programs in the world, the Abramson Cancer Center of the
University of Pennsylvania has 300 active cancer researchers and
300 full-time Penn physicians involved in cancer prevention, diagnosis
and treatment. For more information about specific types of cancer,
cancer treatment, clinical trials, and research advances, visit
the Abramson Cancer Center’s resource on www.penncancer.org
or OncoLink at www.oncolink.org.
The Brain Tumor Society (BTS) was founded
in 1989 as a national nonprofit organization to provide hope and
comfort to patients, survivors and families. BTS improves the quality
of life of brain tumor patients, survivors and their families by
providing access to psychosocial support, information and resources.
BTS also raises funds to advance carefully-selected research projects
to enhance treatments and to find a cure. It has granted $9 million
in research grant awards, including $1.8 million last year alone.
for more information about BTS programs and services and for access
to some of its free informational resources, including the monthly
e-newsletter Head Lines, quarterly newsletter Heads Up, and the
Color Me Hope Resource Guide for patients and families.
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S.News &
World Report's most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the
School of Medicine is recognized worldwide for its superior education
and training of the next generation of physician-scientists and
leaders of academic medicine.
The University of Pennsylvania Health System includes three
hospitals [Hospital of the University of Pennsylvania, which is
consistently ranked one of the nation's few "Honor Roll"
hospitals by U.S.News & World Report; Pennsylvania Hospital,
the nation's first hospital; and Penn Presbyterian Medical Center];
a faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home care and hospice.